Hemosphere Acquisition (Tables) (Hemosphere [Member])

12 Months Ended

Dec. 31, 2013

Hemosphere [Member]

Business Acquisition [Line Items]

Business Acquisition Purchase Price Allocation

	Opening
	Balance Sheet
Cash and cash equivalents	$	3,155
Receivables		653
Inventories		554
Intangible assets		5,790
Goodwill		7,145
Deferred tax assets, net		5,379
Other assets		331
Liabilities assumed		(972)
Total purchase price	$	22,035

Summary Of Unaudited Pro Forma Results Of Operations

	Twelve Months Ended
	December 31,
	2012		2011
Total revenues	$	133,722	$	124,877
Net income		8,758		3,205
Pro forma income per common share - basic	$	0.32	$	0.11
Pro forma income per common share - diluted	$	0.31	$	0.11